Abstract:Objective To evaluate the feasibility of de tecting epidermal growth factor receptor (EGFR) mRNA by reverse transcription po lymerase chain reaction(RT-PCR)in peripheral blood of patients with breast cance r and to explore its significance. Methods RT-PCR assay w as applied to detect the expression of EGFR mRNA in the peripheral blood of 40 p atients with breast cancer and in 30 healthy donors. The result of EGFR mRNA was compared with that of known marker of circulating epithelial cells:CK-19. Results In peripheral blood from 30 healthy donors,none of EGF R mRNA was detected,but the positivity of CK19 mRNA expression was 26.7% (8/ 30) .In contrast ,EGFR mRNA was detected in 13 of 40(32.5%)patients with breast canc er,compared with healthy donors (P0.01),there was significant d ifference between the two groups. CK-19 mRNA was found in 14 of 40(35.0%), compa red with healthy donors (P0.05) and there was no statistical di fference. On the other hand, the expression of EGFR was observed in 25(62.5%) of tumor tissues by immunohistochemistry. We found that all patients who expressed EGFR mRNA in peripheral blood were also expressing EGFR in primary tumors. Pati ents with a high expression of EGFR in tumoral breast tissues display high expre ssion of EGFR in peripheral blood as well(P0.01). EGFR mRNA w as expressed in 5 of 26(19.2%) breast cancer patients without any treatments bef ore, but the positivity for EGFR mRNA expression was 57.1% (8/ 14) in breast can cer patients who have received treatments before. There is significant differenc e between two groups above (P0.05). Expression of EGFR mRNA was detected in 1of 6 (16.7%) metastatic breast cancer patients who have received P aclitaxel involved salvage chemotherapy, however, the positivity for EGFR mRNA e xpression was 87.5% (7/ 8) in them who have never received Paclitaxel contained salvage chemotherapy, there was significant difference between two groups ( P0.05). Conclusion CK-19 mR NA showed no dia gnostic value as marker of circulating tumor cells in breast cancers. However, E GFR mRNA in blood may be a useful marker of circulating tumor cells in breast ca ncers. Detecting EGFR mRNA in peripheral blood of patients with breast cancer us ing RT-PCR can be used as a prognostic indicator. Paclitaxel may reduce the risk of relapse and metastasis of breast cancer.

The studies of peripheral blood T lymphocyte cell rDNA transc ri ption activity in patients with breast cancer

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference Between Mrna and Protein Expression in Predicting Prognosis of Breast Cancer Patients

Screening for Candidate Genes Related to Breast Cancer with Cdna Microarray Analysis

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-polymerase Chain Reaction in Patients with Breast Cancer

Research on the Relationship of Mrna Expressions CEA,Survivin,MMP-2 and TIMP-2 in Peripheral Blood with Breast Carcinoma

Clinical significance of expression rate of cytokines in peripheral blood cells of patients with lung cancer

Expression status of immune related cytokines mRNA in local microenvironment of breast cancer and its clinicopathologic significance

THE LEVEL AND SIGNIFICANCE OF T LYMPHOCYTE SUB-GROUP IN PERIPHERAL BLOOD IN PATIENTS WITH CANCER

Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Expression and Clinical Significance of TRβ1 Gene Mrna in Breast Cancer

Activation of Nucleolar Rrna Gene Transcription in Lymphocytes by Tumor Promoters: Applies Studies with in Situ Hybridization Detected by Fluorescent Method

Expressions of Hmam Mrna and CD44V6 Mrna in Breast Cancer

Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients

Clinical research on detecting multimarker genera in peripheral blood of patients with colorectal carcinoma and its clinical significance

Comparative Study of Detection of Epidermal Growth Factor Receptor and Cytokeratin - 19 Mrna in Peripheral Blood of Breast Cancer Patients by Reverse Transcription Polymerase Chain Reaction

Relationship between CK19 mRNA expression in peripheral blood cells and the clinical factors of breast cancer patients with axillary lymph node-negative

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-Polymerase Chain Reaction in Patients with Colorectal Cancer

The expression and clinical signiifcance of Stanniocalcin-1 in breast cancer

Expression of CK19-mRNA in Cancerous and Paracancerous Tissues and Peripheral Blood of Lung Cancer Patients by Real-time Fluorescent Quantitative RT-PCR and Its Clinical Significance